Location hours
Open
- Sunday:
- Closed
- Monday:
- 8:00 am - 5:00 pm
- Tuesday:
- 8:00 am - 5:00 pm
- Wednesday:
- 8:00 am - 5:00 pm
- Thursday:
- 8:00 am - 5:00 pm
- Friday:
- 8:00 am - 5:00 pm
- Saturday:
- Closed
41.5978199, -93.6231369
Services at this location
Show more
Clinics and amenities at this location
Select office type
Our Care Team
Need help selecting a provider?
When you call 1-515-282-2921 we'll help you find a provider who meets your needs.
Clinical Trials
Mission Cancer + Blood offers a variety of cancer clinical trials at our Des Moines, Laurel Street location.
Patient Stories
March 18, 2026
January 5, 2026
Educational Resources
Awards and Recognition
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - No. 1 in Iowa for Cancer Care
We are proudly ranked No. 1 in Iowa for Cancer Care in the 2026–27 “Adult, Best Hospitals” report.
U.S. News & World Report - Leukemia
In 2026-27 our leukemia program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Lymphoma
In 2026-27 our lymphoma program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Myeloma
In 2026-27 our myeloma program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.